OverviewChartNewsTraderScreen

BFF BANK S.P.A./  IT0005244402  /

Frankfurt
2024-05-23  5:20:01 PM Chg. -0.1900 Volume Bid9:59:59 PM Ask9:59:59 PM High Low
8.9800EUR -2.07% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 9.1100 8.9800
GlobeNewswire 11:25 PM MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoSta...
GlobeNewswire 11:23 PM DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Se...
GlobeNewswire 11:22 PM HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Ha...
GlobeNewswire 11:21 PM INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against In...
GlobeNewswire 11:18 PM Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
Newsfile Corp 11:15 PM American Aires Extends Global Expansion by Opening Latest International Fulfillment Center in the UK
GlobeNewswire 11:15 PM Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of ...
GlobeNewswire 11:13 PM SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Onc...
TeleTrader 11:13 PM SEC approves spot Ethereum ETFs
GlobeNewswire 11:11 PM Special Olympics Florida and Orlando Health Announce Five-Year Partnership
GlobeNewswire 11:10 PM Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-10...
GlobeNewswire 11:09 PM Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant impr...
GlobeNewswire 11:06 PM G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...
GlobeNewswire 11:05 PM Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
GlobeNewswire 11:05 PM BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...
GlobeNewswire 11:05 PM I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire 11:05 PM Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...
GlobeNewswire 11:05 PM Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
GlobeNewswire 11:05 PM FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire 11:05 PM NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...
GlobeNewswire 11:05 PM Elcora Announces Share Consolidation
GlobeNewswire 11:05 PM Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...
GlobeNewswire 11:04 PM Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...
GlobeNewswire 11:03 PM Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...
GlobeNewswire 11:01 PM Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...